Literature DB >> 15642918

Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.

N L Khan1, C Scherfler, E Graham, K P Bhatia, N Quinn, A J Lees, D J Brooks, N W Wood, P Piccini.   

Abstract

Parkin disease is usually autosomal recessive; however, two studies have shown that asymptomatic heterozygotes have nigrostriatal dysfunction and even manifest subtle extrapyramidal signs. The authors used 18F-dopa PET to study 13 asymptomatic parkin heterozygotes and found a significant reduction of (18)F-dopa uptake in caudate, putamen, ventral, and dorsal midbrain compared with control subjects. Four had subtle extrapyramidal signs. Parkin heterozygosity is a risk factor for nigrostriatal dysfunction and in some may contribute to late-onset Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642918     DOI: 10.1212/01.WNL.0000148725.48740.6D

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

Review 1.  Parkinson's disease: a rethink of rodent models.

Authors:  Heather L Melrose; Sarah J Lincoln; Glenn M Tyndall; Matthew J Farrer
Journal:  Exp Brain Res       Date:  2006-04-26       Impact factor: 1.972

2.  A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.

Authors:  D M Kay; C F Stevens; T H Hamza; J S Montimurro; C P Zabetian; S A Factor; A Samii; A Griffith; J W Roberts; E S Molho; D S Higgins; S Gancher; L Moses; S Zareparsi; P Poorkaj; T Bird; J Nutt; G D Schellenberg; H Payami
Journal:  Neurology       Date:  2010-09-28       Impact factor: 9.910

Review 3.  Assessment of the progression of Parkinson's disease: a metabolic network approach.

Authors:  Thomas Eckert; Chengke Tang; David Eidelberg
Journal:  Lancet Neurol       Date:  2007-10       Impact factor: 44.182

4.  Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities.

Authors:  Cheng Wang; Ruifeng Lu; Xuezhi Ouyang; Michelle W L Ho; William Chia; Fengwei Yu; Kah-Leong Lim
Journal:  J Neurosci       Date:  2007-08-08       Impact factor: 6.167

5.  PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.

Authors:  Katarzyna Gaweda-Walerych; Krzysztof Safranow; Barbara Jasinska-Myga; Monika Bialecka; Gabriela Klodowska-Duda; Monika Rudzinska; Krzysztof Czyzewski; Stephanie A Cobb; Jaroslaw Slawek; Maria Styczynska; Grzegorz Opala; Marek Drozdzik; Kenya Nishioka; Matthew J Farrer; Owen A Ross; Zbigniew K Wszolek; Maria Barcikowska; Cezary Zekanowski
Journal:  Parkinsonism Relat Disord       Date:  2012-02-22       Impact factor: 4.891

Review 6.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

7.  The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow.

Authors:  Ozlem Goker-Alpan; Joseph C Masdeu; Philip D Kohn; Angela Ianni; Grisel Lopez; Catherine Groden; Molly C Chapman; Brett Cropp; Daniel P Eisenberg; Emerson D Maniwang; Joie Davis; Edythe Wiggs; Ellen Sidransky; Karen F Berman
Journal:  Brain       Date:  2012-08       Impact factor: 13.501

8.  Syndromic approach to Parkinson's disease: role of functional imaging.

Authors:  Chong Sik Lee; Sun Ju Chung; Jae Seung Kim
Journal:  J Clin Neurol       Date:  2006-06-20       Impact factor: 3.077

9.  Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.

Authors:  J Brooks; J Ding; J Simon-Sanchez; C Paisan-Ruiz; A B Singleton; S W Scholz
Journal:  J Med Genet       Date:  2009-04-06       Impact factor: 6.318

10.  Subclinical sensory abnormalities in unaffected PINK1 heterozygotes.

Authors:  Mirta Fiorio; Enza Maria Valente; Mattia Gambarin; Anna Rita Bentivoglio; Tamara Ialongo; Alberto Albanese; Paolo Barone; Maria Teresa Pellecchia; Francesco Brancati; Giuseppe Moretto; Antonio Fiaschi; Michele Tinazzi
Journal:  J Neurol       Date:  2008-07-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.